Bayer is blueprinting a new production facility to add to its campus in the Bay Area with a $150 million budget to complete the task.
On Thursday the company announced that it will build a bespoke 40,000-square-foot facility on its Berkeley campus, where they already produce hemophilia A products. The plan is to add on clinical production operations at the new Cell Culture Technology Center to support their drug research work in oncology, cardiology and some other specialty health endeavors.
“This investment allows Bayer to expand our biologics development and launch capabilities, as we advance our R&D programs internally and through strategic collaborations,” said Wolfram Carius, head of Bayer Pharmaceuticals Product Supply.
You can look for it to come on line in 2021.
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,200+ biopharma pros who read Endpoints News by email every day.Free Subscription